Cargando…
In-vitro model systems to study Hepatitis C Virus
Hepatitis C virus (HCV) is a major cause of chronic liver diseases including steatosis, cirrhosis and hepatocellular carcinoma. Currently, there is no vaccine available for prevention of HCV infection due to high degree of strain variation. The current treatment of care, Pegylated interferon α in co...
Autores principales: | Ashfaq, Usman Ali, Khan, Shaheen N, Nawaz, Zafar, Riazuddin, Sheikh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083322/ https://www.ncbi.nlm.nih.gov/pubmed/21466709 http://dx.doi.org/10.1186/1479-0556-9-7 |
Ejemplares similares
-
Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
Inhibition of Hepatitis C Virus 3a genotype entry through Glanthus Nivalis Agglutinin
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus
por: Javed, Tariq, et al.
Publicado: (2011) -
An overview of HCV molecular biology, replication and immune responses
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
Inhibition of HCV 3a core gene through Silymarin and its fractions
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)